Gladstone Institutional Advisory’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-17,300
| Closed | -$190K | – | 640 |
|
|
2023
Q1 | $190K | Sell |
17,300
-2,500
| -13% | -$27.4K | 0.01% | 616 |
|
|
2022
Q4 | $85.5K | Sell |
19,800
-33,300
| -63% | -$144K | 0.01% | 621 |
|
|
2022
Q3 | $399K | Sell |
53,100
-19,300
| -27% | -$145K | 0.03% | 434 |
|
|
2022
Q2 | $728K | Sell |
72,400
-7,000
| -9% | -$70.4K | 0.06% | 336 |
|
|
2022
Q1 | $983K | Sell |
79,400
-23,200
| -23% | -$287K | 0.07% | 295 |
|
|
2021
Q4 | $2.35M | Buy |
102,600
+26,100
| +34% | +$597K | 0.18% | 154 |
|
|
2021
Q3 | $1.69M | Sell |
76,500
-12,800
| -14% | -$283K | 0.17% | 162 |
|
|
2021
Q2 | $1.16M | Hold |
89,300
| – | – | 0.14% | 175 |
|
|
2021
Q1 | $1.16M | Sell |
89,300
-2,450
| -3% | -$31.8K | 0.18% | 126 |
|
|
2020
Q4 | $1.27M | Buy |
91,750
+19,000
| +26% | +$263K | 0.25% | 88 |
|
|
2020
Q3 | $1.07M | Buy |
72,750
+10,850
| +18% | +$160K | 0.26% | 90 |
|
|
2020
Q2 | $1.01M | Buy |
61,900
+6,998
| +13% | +$114K | 0.26% | 83 |
|
|
2020
Q1 | $797K | Buy |
+54,902
| New | +$797K | 0.21% | 102 |
|